Dihydroartemisinin for female hair loss
Treatments studied
Part of Skin clinical trials.
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with female pattern hair loss (androgenetic alopecia).
- You do not plan to become pregnant in the next 6 months.
- You have not used any oral or injected hair loss medications in the past 2 months.
- You have not used any topical (applied to skin) hair loss treatments in the past 2 weeks.
- You are not pregnant or breastfeeding.
- You do not have a serious disease affecting your heart, liver, kidneys, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a low-dose oral form of minoxidil (a hair growth medicine) for people with pattern hair loss. It aims to see if this treatment helps regrow hair in a convenient way.
This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
This study tests if a medicine called dihydroartemisinin (a type of artemisinin, often used for malaria) can help treat acne when applied to the skin. It's a small early-phase trial for people with acne vulgaris.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.